Skip to main content

Table 4 Comparison of AUC-CSHtotal and AUC-CSH40% between different subgroups

From: The prognostic value of 18F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients

Variable AUC-CSH40% P AUC-CSHtotal P
COG    0.965   0.018*
  Low and medium risk 0.560±0.060   0.506±0.108  
  High risk 0.561±0.039   0.431±0.079  
BMI
  No 0.563±0.070 0.914 0.516±0.113 0.030*
  Yes 0.560±0.038   0.441±0.007  
MYCN
  Normal 0.560±0.054 0.947 0.465±0.113 0.861
  Acquired and amplify 0.561±0.039   0.459±0.077  
EFS
  Without event 0.581±0.049 0.009* 0.515±0.101 <0.001*
  With event 0.541±0.039   0.410±0.062  
  1. COG Children's Oncology Group, BMI bone morrow involvement, MYCN myelocytomatosis viral oncogene neuroblastoma derived homolog, EFS event-free survival, AUC-CSH areas under the curve of cumulative SUV-volume histogram, *P < 0.05